Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 9 | $22,849,651 |
| Sells | 50 | $59,026,019 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 05 Aug 2024 16:30 | OLMA | Olema Pharmaceuticals Inc | PARADIGM BIOCAPITAL ADVISORS LP | 10% | 01 Aug 2024 | Sale | 529,501 | 14.915 | 7,897,507 | I |
| 05 Aug 2024 16:30 | OLMA | Olema Pharmaceuticals Inc | PARADIGM BIOCAPITAL ADVISORS LP | 10% | 01 Aug 2024 | Sale | 1,870,499 | 14.915 | 27,898,493 | I |
| 31 Jul 2024 17:15 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 29 Jul 2024 | Sale | 4,066 | 15.58 | 63,348 | D |
| 31 Jul 2024 17:15 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 30 Jul 2024 | Sale | 934 | 15.55 | 14,524 | D |
| 12 Jul 2024 17:15 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 11 Jul 2024 | Sale | 5,000 | 12.26 | 61,300 | D |
| 02 Jul 2024 17:30 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 28 Jun 2024 | Sale | 20,000 | 10.77 | 215,400 | D |
| 06 Jun 2024 17:01 | OLMA | Olema Pharmaceuticals Inc | GRAHAM G. WALMSLEY | Director | 04 Jun 2024 | Sale | 475,000 | 14.85 | 7,053,750 | I |
| 06 Jun 2024 17:01 | OLMA | Olema Pharmaceuticals Inc | GRAHAM G. WALMSLEY | Director | 04 Jun 2024 | Sale | 700,000 | 14.85 | 10,395,000 | I |
| 04 Jun 2024 21:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 03 Jun 2024 | Sale | 5,000 | 10.93 | 54,650 | D |
| 04 Jun 2024 21:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 04 Jun 2024 | Sale | 5,000 | 12.33 | 61,650 | D |
| 04 Jun 2024 21:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 31 May 2024 | Sale | 15,000 | 9.41 | 141,150 | D |
| 07 May 2024 17:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 06 May 2024 | Sale | 5,000 | 10.92 | 54,600 | D |
| 02 May 2024 17:09 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 30 Apr 2024 | Sale | 15,000 | 9.51 | 142,650 | D |
| 29 Mar 2024 17:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 28 Mar 2024 | Sale | 20,000 | 10.97 | 219,400 | D |
| 04 Mar 2024 17:30 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 29 Feb 2024 | Sale | 100 | 13 | 1,300 | D |
| 04 Mar 2024 17:30 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 29 Feb 2024 | Sale | 24,900 | 12.41 | 309,009 | D |
| 02 Feb 2024 17:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 01 Feb 2024 | Sale | 5,000 | 15.56 | 77,800 | D |
| 02 Feb 2024 17:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 31 Jan 2024 | Sale | 25,000 | 12.23 | 305,750 | D |
| 02 Jan 2024 17:30 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 29 Dec 2023 | Sale | 2,500 | 14.1 | 35,250 | D |
| 02 Jan 2024 17:30 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 29 Dec 2023 | Sale | 22,500 | 13.3 | 299,250 | D |
| 18 Dec 2023 18:30 | OLMA | Olema Pharmaceuticals Inc | GRAHAM G. WALMSLEY | Director | 05 Dec 2023 | Purchase | 50,000 | 13.085 | 654,250 | I |
| 18 Dec 2023 18:30 | OLMA | Olema Pharmaceuticals Inc | GRAHAM G. WALMSLEY | Director | 05 Dec 2023 | Purchase | 50,000 | 14.9496 | 747,480 | I |
| 18 Dec 2023 18:30 | OLMA | Olema Pharmaceuticals Inc | GRAHAM G. WALMSLEY | Director | 12 Sep 2023 | Purchase | 508,130 | 9.84 | 4,999,999 | I |
| 18 Dec 2023 18:30 | OLMA | Olema Pharmaceuticals Inc | GRAHAM G. WALMSLEY | Director | 05 Dec 2023 | Purchase | 31,870 | 14.7333 | 469,550 | I |
| 08 Dec 2023 16:19 | OLMA | Olema Pharmaceuticals Inc | PARADIGM BIOCAPITAL ADVISORS LP | 10% | 06 Dec 2023 | Purchase | 100,000 | 11.6 | 1,160,000 | I |
| 01 Dec 2023 17:15 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 30 Nov 2023 | Sale | 25,000 | 12.57 | 314,250 | D |
| 22 Nov 2023 19:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 22 Nov 2023 | Sale | 3,989 | 13.9 | 55,447 | D |
| 22 Nov 2023 19:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 21 Nov 2023 | Sale | 4,192 | 14.86 | 62,293 | D |
| 22 Nov 2023 19:00 | OLMA | Olema Pharmaceuticals Inc | ZOJWALLA NASEEM | CHIEF MEDICAL OFFICER | 22 Nov 2023 | Sale | 7,095 | 13.89 | 98,550 | D |
| 22 Nov 2023 19:00 | OLMA | Olema Pharmaceuticals Inc | ZOJWALLA NASEEM | CHIEF MEDICAL OFFICER | 21 Nov 2023 | Sale | 200 | 15.33 | 3,066 | D |
| 22 Nov 2023 19:00 | OLMA | Olema Pharmaceuticals Inc | ZOJWALLA NASEEM | CHIEF MEDICAL OFFICER | 21 Nov 2023 | Sale | 7,261 | 14.83 | 107,681 | D |
| 22 Nov 2023 19:00 | OLMA | Olema Pharmaceuticals Inc | MYLES DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | 22 Nov 2023 | Sale | 6,653 | 13.89 | 92,410 | D |
| 22 Nov 2023 19:00 | OLMA | Olema Pharmaceuticals Inc | MYLES DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | 21 Nov 2023 | Sale | 200 | 15.32 | 3,064 | D |
| 22 Nov 2023 19:00 | OLMA | Olema Pharmaceuticals Inc | MYLES DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | 21 Nov 2023 | Sale | 6,776 | 14.87 | 100,759 | D |
| 22 Nov 2023 19:00 | OLMA | Olema Pharmaceuticals Inc | BOHEN SEAN | PRESIDENT AND CEO | 22 Nov 2023 | Sale | 27,932 | 13.9 | 388,255 | D |
| 22 Nov 2023 19:00 | OLMA | Olema Pharmaceuticals Inc | BOHEN SEAN | PRESIDENT AND CEO | 21 Nov 2023 | Sale | 2,602 | 15.29 | 39,785 | D |
| 22 Nov 2023 19:00 | OLMA | Olema Pharmaceuticals Inc | BOHEN SEAN | PRESIDENT AND CEO | 21 Nov 2023 | Sale | 26,691 | 14.84 | 396,094 | D |
| 22 Nov 2023 19:00 | OLMA | Olema Pharmaceuticals Inc | KOVACS SHANE WILLIAM CHARLES | CH. OPERATING & FINANCIAL OFF. | 21 Nov 2023 | Sale | 700 | 15.27 | 10,689 | D |
| 22 Nov 2023 19:00 | OLMA | Olema Pharmaceuticals Inc | KOVACS SHANE WILLIAM CHARLES | CH. OPERATING & FINANCIAL OFF. | 22 Nov 2023 | Sale | 9,145 | 13.89 | 127,024 | D |
| 22 Nov 2023 19:00 | OLMA | Olema Pharmaceuticals Inc | KOVACS SHANE WILLIAM CHARLES | CH. OPERATING & FINANCIAL OFF. | 21 Nov 2023 | Sale | 8,897 | 14.83 | 131,943 | D |
| 13 Nov 2023 17:30 | OLMA | Olema Pharmaceuticals Inc | MYLES DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | 08 Nov 2023 | Sale | 200 | 17.61 | 3,522 | D |
| 03 Nov 2023 21:39 | OLMA | Olema Pharmaceuticals Inc | MYLES DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | 03 Nov 2023 | Sale | 541 | 17.51 | 9,473 | D |
| 03 Nov 2023 21:39 | OLMA | Olema Pharmaceuticals Inc | MYLES DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | 02 Nov 2023 | Sale | 3,332 | 15.36 | 51,180 | D |
| 03 Nov 2023 21:39 | OLMA | Olema Pharmaceuticals Inc | MYLES DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | 01 Nov 2023 | Sale | 6,668 | 15.02 | 100,153 | D |
| 02 Nov 2023 20:50 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 02 Nov 2023 | Sale | 5,000 | 15.64 | 78,200 | D |
| 02 Nov 2023 20:50 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 31 Oct 2023 | Sale | 25,000 | 12.05 | 301,250 | D |
| 03 Oct 2023 17:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 29 Sep 2023 | Sale | 25,000 | 12.41 | 310,250 | D |
| 21 Sep 2023 17:00 | OLMA | Olema Pharmaceuticals Inc | MYLES DAVID C. | CH. DISCOV. & NON-CLIN DEV OFF | 19 Sep 2023 | Sale | 20,000 | 12.67 | 253,400 | D |
| 14 Sep 2023 16:25 | OLMA | Olema Pharmaceuticals Inc | BVF PARTNERS L P/IL | Director , 10% | 12 Sep 2023 | Purchase | 52,801 | 9.84 | 519,562 | D |
| 14 Sep 2023 16:25 | OLMA | Olema Pharmaceuticals Inc | BVF PARTNERS L P/IL | Director , 10% | 12 Sep 2023 | Purchase | 677,853 | 9.84 | 6,670,074 | D |
| 14 Sep 2023 16:25 | OLMA | Olema Pharmaceuticals Inc | BVF PARTNERS L P/IL | Director , 10% | 12 Sep 2023 | Purchase | 775,278 | 9.84 | 7,628,736 | D |
| 05 Sep 2023 21:08 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 05 Sep 2023 | Sale | 10,000 | 11.62 | 116,200 | D |
| 05 Sep 2023 21:08 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 31 Aug 2023 | Sale | 15,000 | 9.36 | 140,400 | D |
| 05 Sep 2023 16:05 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 16 Aug 2023 | Sale A | 15,000 | 10.14 | 152,100 | D |
| 17 Aug 2023 17:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 16 Aug 2023 | Sale | 15,000 | 10.14 | 152,100 | D |
| 09 Jun 2023 17:30 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 08 Jun 2023 | Sale | 10,000 | 6.3 | 63,000 | D |
| 07 Jun 2023 21:30 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 06 Jun 2023 | Sale | 5,000 | 6.295 | 31,475 | D |
| 07 Jun 2023 21:30 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 05 Jun 2023 | Sale | 5,000 | 6.045 | 30,225 | D |
| 07 Apr 2023 16:30 | OLMA | Olema Pharmaceuticals Inc | KOVACS SHANE WILLIAM CHARLES | CH. OPERATING & FINANCIAL OFF. | 06 Apr 2023 | Purchase | 10,000 | 0 | 0 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)